Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis Post author: Post published:May 29, 2024 Post category:uncategorized The antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced keratitis You Might Also Like Study reveals altered protein rhythms linked to metabolic disorders in night shift workers May 9, 2024 Huntington’s disease symptoms reduced by new peptide-polymer therapy November 3, 2024 Mechanical stretching boosts stem cell therapy for diabetic wounds August 7, 2025
Study reveals altered protein rhythms linked to metabolic disorders in night shift workers May 9, 2024